Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis

International Journal of Pediatric Otorhinolaryngology

Volumn 75, Issue 11, 2011, Pages 1364-1367

  Koc, Sema ^a   Aksoy, Nurten ^b   Bilinc, Hasan ^b   Duygu, Fazilet ^c   Uysal, Ismail Önder ^d   Ekinci, Adnan ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

^c Tokat State Hospital   (Turkey)

^d CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Adenoidectomy; Arylesterase; Oxidative stress index; Paraoxonase; Tonsillectomy; Total antioxidant status; Total oxidant status

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; OXIDIZING AGENT;

ADENOIDECTOMY; ADENOTONSILLECTOMY; ARTICLE; BLOOD SAMPLING; CHILD; CHRONIC ADENOTONSILLITIS; CHRONIC TONSILLITIS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; OXIDATIVE STRESS INDEX; PHYSICAL PARAMETERS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT INFECTION; SCHOOL CHILD; TOTAL ANTIOXIDANT STATUS; TOTAL OXIDANT STATUS;

ADENOIDECTOMY; ADENOIDS; ADOLESCENT; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CARBOXYLIC ESTER HYDROLASES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NASOPHARYNGITIS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TONSILLECTOMY; TONSILLITIS; TREATMENT OUTCOME;

EID: 80053964783     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2011.07.017     Document Type: Article

References (34)

1. Verma S.P., Stoddard T., Gonzalez-Gomez I., Koempel J.A. Histologic analysis of pediatric tonsil and adenoid specimens: is it really necessary?. Int. J. Pediatr. Otorhinolaryngol. 2009, 73:547-550.
2. Kaygusuz I., Ilhan N., Karlidag T., Keles E., Yalçin S., Cetiner H. Free radicals and scavenging enzymes in chronic tonsillitis. Otolaryngol. Head Neck Surg. 2003, 129:265-268.
3. Serafini M., Del Rio D. Understanding the association between dietary antioxidants redox status and disease: is the total antioxidant capacity the right tool?. Redox Rep. 2004, 9:145-152.
4. Doĝruer Z.N., Unal M., Eskandari G., Pata Y.S., Akbaş Y., Cevik T., et al. Malondialdehyde and antioxidant enzymes in children with obstructive adenotonsillar hypertrophy. Clin. Biochem. 2004, 37:718-721.
5. Yilmaz T., Koçan E.G., Besler H.T. The role of oxidants and antioxidants in chronic tonsillitis and adenoid hypertrophy in children. Int. J. Pediatr. Otorhinolaryngol. 2004, 68:1053-1058.
6. Selek S., Cosar N., Kocyigit A., Erel O., Aksoy N., Gencer M., et al. PON1 activity and total oxidant status in patients with active pulmonary tuberculosis. Clin. Biochem. 2008, 41:140-144.
7. Erdem F.H., Karatay S., Yildirim K., Kiziltunc A. Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients. Clinics 2010, 65:175-179.
8. Seres I., Pragh G., Deschene Fulop T., Khalil A. Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp. Gerontol. 2004, 39:59-66.
9. Eckerson H.W., Wyte M.C., La Du B.N. The human serum paroxonase/arylesterase polymorphism. Am. J. Hum. Genet. 1983, 35:1126-1138.
10. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin. Biochem. 2005, 38:1103-1111.
11. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin. Biochem. 2004, 37:112-119.
12. Aslan M., Kosecik M., Horoz M., Selek S., Celik H., Erel O. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Atherosclerosis 2007, 191:397-402.
13. Latha B., Babu M. The involvement of free radicals in burn injury: a review. Burns 2001, 27:309-317.
14. Mackness B., Durrington P.N., Mackness M.I. Human serum paraoxonase. Gen. Pharmacol. 1998, 31:329-336.
15. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Faull K.F., Fogelman A.M., et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 1995, 96:2882-2891.
16. Verit F.F., Verit A., Ciftci H., Erel O., Celik H. Paraoxonase-1 activity in subfertile men and relationship to sperm parameters. J. Androl. 2009, 30:183-189.
17. Ece A., Atamer Y., Gürkan F., Davutoĝlu M., Bilici M., Tutanç M., et al. Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure. Pediatr. Nephrol. 2006, 21:239-245.
18. Farid A.S., Nakahara K., Murakami N., Hayashi T., Horii Y. Decreased serum paraoxonase-1 activity during intestinal nematode (Nippostrongylus brasiliensis) infection in rats. Am. J. Trop. Med. Hyg. 2008, 78:770-776.
19. Parra S., Alonso-Villaverde C., Coll B., Ferré N., Marsillach J., Aragonès G., et al. Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection. Atherosclerosis 2007, 194:175-181.
20. Schulpis K.H., Barzeliotou A., Papadakis M., Rodolakis A., Antsaklis A., Papassotiriou I., et al. Maternal chronic hepatitis B virus is implicated with low neonatal paraoxonase/arylesterase activities. Clin. Biochem. 2008, 41:282-287.
21. Apostolou F., Gazi I.F., Lagos K., Tellis C.C., Tselepis A.D., Liberopoulos E.N., et al. Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes. Atherosclerosis 2010, 212:607-613.
22. Camuzcuoglu H., Arioz D.T., Toy H., Kurt S., Celik H., Erel O. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer. Gynecol. Oncol. 2009, 112:481-485.
23. Cakmak A., Zeyrek D., Atas A., Selek S., Erel O. Oxidative status and paraoxonase activity in children with asthma. Clin. Invest. Med. 2009, 32:327-334.
24. Shih D.M., Lusis A.J. The roles of PON1 and PON2 in cardiovascular disease and innate immunity. Curr. Opin. Lipidol. 2009, 20:288-292.
25. Tanimoto N., Kumon Y., Suehiro T., Ohkubo S., Ikeda Y., Nishiya K., et al. Serum paraoxonase activity decreases in rheumatoid arthritis. Life Sci. 2003, 72:2877-2885.
26. Kiss E., Seres I., Tarr T., Kocsis Z., Szegedi G., Paragh G. Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 2007, 1108:83-91.
27. Toker A., Kadi M., Yildirim A.K., Aksoy H., Akçay F. Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem. Funct. 2009, 27:176-180.
28. Karakucuk S., Baskol G., Oner A.O., Baskol M., Mirza E., Ustdal M. Serum paraoxonase activity is decreased in the active stage of Behçet's disease. Br. J. Ophthalmol. 2004, 88:1256-1258.
29. Kiroglu A.F., Noyan T., Oger M., Kara T. Oxidants and antioxidants in tonsillar and adenoidal tissue in chronic adenotonsillitis and adenotonsillar hypertrophy in children. Int. J. Pediatr. Otorhinolaryngol. 2006, 70:35-38.
30. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin. Biochem. 2004, 37:277-285.
31. Cao G., Prior R.L. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin. Chem. 1998, 44:1309-1315.
32. Virit O., Altindag A., Yumru M., Dalkilic A., Savas H.A., Selek S., et al. A defect in the antioxidant defense system in schizophrenia. Neuropsychobiology 2009, 60:87-93.
33. Serefhanoglu K., Taskin A., Turan H., Timurkaynak F.E., Arslan H., Erel O. Evaluation of oxidative status in patients with brucellosis. Braz. J. Infect. Dis. 2009, 13:249-251.
34. Naderi M., Hashemi M., Komijani-Bozchaloei F., Moazeni-Roodi A., Momenimoghaddam M. Serum paraoxonase and arylesterase activities in patients with pulmonary tuberculosis. Pathophysiology 2010, [December 2; Epub ahead of print].